Gepants for Migraine Prevention: A Perfect Fit for Primary Care
Episode 14 of the Patient Care Online Primary Viewpoints podcast is now live! Scroll down to listen or click here to subscribe on your favorite streaming service.
The Primary Viewpoints podcast features informative conversations with health care experts, opinion leaders, and practicing physicians, about what impacts primary care medicine today.
In episode 14, headache specialist Dr Peter McAllister discusses the first FDA-approved migraine-specific oral preventive treatments in the gepant class and the role these medications may play in treatment of migraine in primary care settings.
Peter McAllister, MD, is medical director of the New England Institute for Neurology and Headache and chief medical officer of the Chief Medical Officer, New England Institute for Clinical Research, both located in Stamford, CT.
Click here to subscribe to the Primary Viewpoints podcast. Be sure to leave a rating and review for the show. Thanks for listening!
The CMS CED Policy Limits Treatment for Early Alzheimer's Disease: What It Is and How It Works
December 16th 2024The coverage with evidence development (CED) policy requires enrollment in an active clinical trial for an adult to be eligible for Medicare coverage of treatment for Alzheimer's disease.
